BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9082380)

  • 1. [Idiopathic focal dystonia of the foot in a 98-year-old-woman. Treatment with botulin toxin].
    Verlhac B; Dobigny-Roman N; Forette B
    Presse Med; 1996 Dec; 25(40):2042. PubMed ID: 9082380
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical therapy and botulinum toxin in dystonia.
    Jankovic J
    Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
    [No Abstract]   [Full Text] [Related]  

  • 3. Immediate response to botulinum toxin injections in patients with fixed dystonia.
    Edwards MJ; Bhatia KP; Cordivari C
    Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of botulinum toxin in head and neck disorders.
    Hawthorne MR
    Hosp Med; 2003 Aug; 64(8):460-3. PubMed ID: 12958756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laryngeal dystonia].
    Barbosa ER
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):829. PubMed ID: 11593295
    [No Abstract]   [Full Text] [Related]  

  • 12. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin: potent poison, potent medicine.
    Simpson LL
    Hosp Pract (1995); 1999 Apr; 34(4):87-91; quiz 163. PubMed ID: 10212633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type F for treatment of dystonia: long-term experience.
    Chen R; Karp BI; Hallett M
    Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.
    Bell MS; Vermeulen LC; Sperling KB
    Pharmacotherapy; 2000 Sep; 20(9):1079-91. PubMed ID: 10999501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin: historical perspective and potential new indications.
    Jankovic J; Brin MF
    Muscle Nerve Suppl; 1997; 6():S129-45. PubMed ID: 9826986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.